Cyteir Therapeutics Probability of Future Stock Price Finishing Under 2.76
| CYTDelisted Stock | USD 2.76 0.01 0.36% |
Cyteir |
Cyteir Therapeutics Target Price Odds to finish below 2.76
The tendency of Cyteir Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move below current price in 90 days |
| 2.76 | 90 days | 2.76 | over 95.96 |
Based on a normal probability distribution, the odds of Cyteir Therapeutics to move below current price in 90 days from now is over 95.96 (This Cyteir Therapeutics probability density function shows the probability of Cyteir Stock to fall within a particular range of prices over 90 days) .
Considering the 90-day investment horizon the stock has the beta coefficient of 1.35 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Cyteir Therapeutics will likely underperform. Additionally Cyteir Therapeutics has an alpha of 0.406, implying that it can generate a 0.41 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Cyteir Therapeutics Price Density |
| Price |
Predictive Modules for Cyteir Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Cyteir Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cyteir Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Cyteir Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Cyteir Therapeutics is not an exception. The market had few large corrections towards the Cyteir Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Cyteir Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Cyteir Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.41 | |
β | Beta against Dow Jones | 1.35 | |
σ | Overall volatility | 0.28 | |
Ir | Information ratio | 0.08 |
Cyteir Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Cyteir Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Cyteir Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Cyteir Therapeutics is not yet fully synchronised with the market data | |
| Cyteir Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Reported Net Loss for the year was (33.22 M) with loss before taxes, overhead, and interest of (16.59 M). | |
| Cyteir Therapeutics has about 166.4 M in cash with (25.79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.71, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Over 77.0% of the company shares are held by institutions such as insurance companies |
Cyteir Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Cyteir Stock often depends not only on the future outlook of the current and potential Cyteir Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cyteir Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 35.3 M | |
| Cash And Short Term Investments | 147.1 M | |
| Shares Float | 10.8 M |
Cyteir Therapeutics Technical Analysis
Cyteir Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Cyteir Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Cyteir Therapeutics. In general, you should focus on analyzing Cyteir Stock price patterns and their correlations with different microeconomic environments and drivers.
Cyteir Therapeutics Predictive Forecast Models
Cyteir Therapeutics' time-series forecasting models is one of many Cyteir Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Cyteir Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Cyteir Therapeutics
Checking the ongoing alerts about Cyteir Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Cyteir Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Cyteir Therapeutics is not yet fully synchronised with the market data | |
| Cyteir Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Reported Net Loss for the year was (33.22 M) with loss before taxes, overhead, and interest of (16.59 M). | |
| Cyteir Therapeutics has about 166.4 M in cash with (25.79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.71, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Over 77.0% of the company shares are held by institutions such as insurance companies |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Consideration for investing in Cyteir Stock
If you are still planning to invest in Cyteir Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cyteir Therapeutics' history and understand the potential risks before investing.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |